Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01291797 · ClinicalTrials.gov registry record
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01291797 is a clinical trial that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 4 participants.
The verdict
NCT01291797 was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study aims to examine performance on a neurological screening test, the Dubowitz, and sleep wake cycles on amplitude integrated electroencephalogram (AEEG) in neonates with congenital heart disease (CHD) as a way to potentially predict longterm motor outcome. It will compare the results of these studies to neonates without CHD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01291797
The ClinicalTrials.gov registry entry for NCT01291797 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01291797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01291797 about?
NCT01291797 is a clinical study titled "Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease". This study aims to examine performance on a neurological screening test, the Dubowitz, and sleep wake cycles on amplitude integrated electroencephalogram (AEEG) in neonates with congenital heart disease (CHD) as a way to potentially predict longterm motor outcome. It will compare the results of thes...
What is the current status of trial NCT01291797?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2010-07. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01291797?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.